The Risk of Recurrence in Breast Cancer Patients Treated with Tamoxifen: Polymorphisms of CYP2D6 and ABCB1
Journal Title: The AAPS Journal - Year 2012, Vol 14, Issue 1
Abstract
CYP2D6 plays a major role in the metabolism of tamoxifen, and polymorphism of P-glycoprotein has been associated with resistance of many drug therapies. This study investigates the clinical impact of genetic variants of CYP2D6 and ABCB1 in breast cancer patients treated with tamoxifen. Blood samples from 95 breast cancer patients treated with tamoxifen were collected and genotyped for CYP2D6 and ABCB1 variants using allele-specific PCR method. Recurrence risks were calculated using Kaplan–Meier analysis and compared using the log-rank test. Patients carrying CYP2D6*10/*10 and heterozygous null allele (IM) showed higher risks of developing recurrence and metastasis (OR 13.14; 95% CI 1.57–109.94; P = 0.004) than patients with CYP2D6*1/*1 and *1/*10 genotypes. Patients with homozygous CC genotypes of ABCB1 C3435T showed a shorter time to recurrence. Patients who were CYP2D6 IM and homozygous CC genotype of C3435T have statistically significant higher risks of recurrence (P = 0.002). Similarly, median time to recurrence in these patients was only 12 months (95% CI = 0.79–23.2) compared to those without this combination which was 48 months (95% CI = 14.7–81.2). Patients with CYP2D6 IM and homozygous CC genotype of ABCB1 C3435T have shorter times to recurrence. The results confirmed the findings of previous studies and support FDA recommendation to perform pre-genotyping in patients before the choice of therapy is determined in breast cancer patients.
Authors and Affiliations
L. K. Teh, N. I. Mohamed, M. Z. Salleh, M. Rohaizak, N. S. Shahrun, J. J. Saladina, J. K. S. Shia, H. Roslan, S. Sood, T. S. Rajoo, S. P. Muniandy, G. Henry, H. A. Ngow, K. T. Hla U, J. Din
Keywords
Related Articles
- EP ID EP681187
- DOI 10.1208/s12248-011-9313-6
- Views 49
- Downloads 0
Cellular uptake and concentrations of tamoxifen upon administration in poly(ε-caprolactone) nanoparticles
Purpose: In an attempt to increase the local concentration of tamoxifen in estrogen receptor positive breast cancer cells, we have prepared and characterized poly (ε-caprolactone) (PCL) nanoparticle formulation....
Ligand Binding Assays in the 21st Century Laboratory: Automation
Many manufacturers offer well-designed instrument-specific authentication built into the automated system software. Instrument-specific security often contains thorough system tracking and audit trail generation for ensu...
Erratum to: Regioselective Glucuronidation of Andrographolide and Its Major Derivatives: Metabolite Identification, Isozyme Contribution, and Species Differences
Xiangge Tian and Sicheng Liang contributed equally to this work.
Estimation of Biliary Excretion of Foreign Compounds Using Properties of Molecular Structure
The online version of this article (doi:10.1208/s12248-013-9541-z) contains supplementary material, which is available to authorized users.
Optimal Design in Population Kinetic Experiments by Set-Valued Methods
The online version of this article (doi:10.1208/s12248-011-9291-8) contains supplementary material, which is available to authorized users.